Stryker Beats Quarterly Estimates on Strong Demand for Medical Devices

Stryker falls despite Q2 beats

Stryker stock drops 8% after hours despite Q2 EPS beat; 2026 organic sales and non-GAAP EPS guidance narrowed. Read more here.

Stryker beats quarterly estimates on strong demand for medical devices

July 30 (Reuters) - U.S. medical device maker Stryker on Thursday beat Wall Street estimates for second-quarter results, aided by strong ​demand for its implants and devices used ‌in complex procedures ranging from spinal to orthopedic surgeries. Howev...

Stryker Narrows Earnings Outlook as Cyberattack Challenges Goals

Stryker Corp narrowed the range of its adjusted-earnings outlook for the full year as the medical device manufacturer said it must increase production as well as ship a backlog of equipment to meet its second-half growth targets after a cyberattack in March disrupted operations.

What Is Driving Interest in Stryker (NYSE:SYK) Ahead of Earnings?

Stryker (NYSE:SYK) Q2 earnings preview explores medical technology operations, healthcare products and business developments within the S&P 500 before quarterly financial results release.